| Model Number |
407665 |
| Medical Device Problem Codes |
Signal Artifact/Noise (1036); Electrical /Electronic Property Problem (1198); Fracture (1260); High impedance (1291); Over-Sensing (1438)
|
| Health Effect - Clinical Codes |
Bradycardia (1751); Dizziness (2194); Syncope/Fainting (4411); Asystole (4442)
|
| Date of Event |
03/03/2025
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
Product event summary: the full lead was returned, analyzed, and no anomalies were found.Visual analysis of the lead indicated apparent explant damage.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
It was reported that the patient collapsed and was in a neck brace.The patient experienced asystole, bradycardia dizziness and syncope.An interrogation report indicated that the right ventricular (rv) lead triggered an alert for out of range (oor) high impedance and a polarity switch as triggered.In addition, the rv lead exhibited oversensing with possible noise on stored electrograms (egm) and had a high number of short v-v intervals.A low voltage lead fracture was confirmed.The lead was removed and replaced.No further patient complications have been reported as a result of this event.
|
| |
|
Additional Manufacturer Narrative
|
|
Product event summary: the full lead was returned and analyzed.The analysis indicated that the lv1/distal conductor was fractured in-vivo in the anchoring sleeve area.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Search Alerts/Recalls
|